Announcement under Regulation 30 (LODR)-Investor Presentation

Summary by 6ix AI

Fermenta Biotech Ltd has submitted an earnings presentation for the second quarter and first half of the fiscal year, detailing financial performance and operational highlights. The presentation indicates that human nutrition has become a significant revenue source, contributing over half of the company's income, while animal nutrition prices have adjusted. Key financial metrics show a decline in profit and total income compared to the previous year, attributed to lower animal nutrition prices and a lack of one-off gains seen in the prior period. The company emphasizes its strategic position to meet growing global health and nutrition demands, supported by innovations in green chemistry and a diverse product portfolio.

Written by 6ix AI from the company’s filing. How 6ix writes summaries